Articles written by: Davis Scott

Stealth BioTherapeutics Corp (MITO) and Mesoblast Limited (NASDAQ:MESO) Comparing side by side

This is therefore a comparing of the analyst recommendations, profitability, risk, dividends, institutional ownership, earnings and valuation in Stealth BioTherapeutics Corp (NASDAQ:MITO) and Mesoblast Limited (NASDAQ:MESO). The two are both Biotechnology companies that compete with one another. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings […]

Donegal Group Inc. (DGICA)’s Financial Results Comparing With Mercury General Corporation (NYSE:MCY)

This is a contrast between Donegal Group Inc. (NASDAQ:DGICA) and Mercury General Corporation (NYSE:MCY) based on their dividends, analyst recommendations, profitability, risk, institutional ownership, earnings and valuation. The two companies are Property & Casualty Insurance and they also compete with each other. Valuation and Earnings Gross Revenue Price/Sales Ratio Net […]

Seelos Therapeutics Inc. (SEEL)’s Financial Results Comparing With CohBar Inc. (NASDAQ:CWBR)

This is a contrast between Seelos Therapeutics Inc. (NASDAQ:SEEL) and CohBar Inc. (NASDAQ:CWBR) based on their risk, analyst recommendations, profitability, institutional ownership, dividends, earnings and valuation. The two companies are Biotechnology and they also compete with each other. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share […]

Contrasting of Titan Pharmaceuticals Inc. (TTNP) and Axsome Therapeutics Inc. (NASDAQ:AXSM)

Titan Pharmaceuticals Inc. (NASDAQ:TTNP) and Axsome Therapeutics Inc. (NASDAQ:AXSM) compete with each other in the Biotechnology sector. We will analyze and contrast their analyst recommendations, profitability, risk, dividends, institutional ownership, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Titan Pharmaceuticals Inc. […]

Intellia Therapeutics Inc. (NTLA)’s Financial Results Comparing With GlycoMimetics Inc. (NASDAQ:GLYC)

Intellia Therapeutics Inc. (NASDAQ:NTLA) and GlycoMimetics Inc. (NASDAQ:GLYC), are influenced by compare since they are both players in the Biotechnology. These factors are particularly influence the analyst recommendations, profitability, risk, institutional ownership, dividends, earnings and valuation of the two firms. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings […]

Helmerich & Payne Inc. (HP) and Cenovus Energy Inc. (NYSE:CVE) Contrasting side by side

Both Helmerich & Payne Inc. (NYSE:HP) and Cenovus Energy Inc. (NYSE:CVE) compete on a level playing field in the Oil & Gas Drilling & Exploration industry. We will evaluate their performance with regards to institutional ownership, profitability, risk, dividends, analyst recommendations, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales […]

Contrasting of Opiant Pharmaceuticals Inc. (OPNT) and Cellect Biotechnology Ltd. (NASDAQ:APOP)

Both Opiant Pharmaceuticals Inc. (NASDAQ:OPNT) and Cellect Biotechnology Ltd. (NASDAQ:APOP) are Biotechnology companies, competing one another. We will contrast their dividends, analyst recommendations, profitability, institutional ownership, risk, earnings and valuation. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Opiant Pharmaceuticals Inc. 13.98M 3.16 21.20M […]

Minerva Neurosciences Inc. (NERV)’s Financial Results Comparing With Spark Therapeutics Inc. (NASDAQ:ONCE)

As Biotechnology businesses, Minerva Neurosciences Inc. (NASDAQ:NERV) and Spark Therapeutics Inc. (NASDAQ:ONCE), are affected by contrast. This especially applies to their institutional ownership, earnings and valuation, profitability, risk, dividends, analyst recommendations. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Minerva Neurosciences Inc. N/A 0.00 […]